SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-133880
Filing Date
2019-05-02
Accepted
2019-05-02 08:00:58
Documents
3
Period of Report
2019-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d723951d8k.htm 8-K 35187
2 EX-10.1 d723951dex101.htm EX-10.1 596329
3 EX-10.2 d723951dex102.htm EX-10.2 231311
  Complete submission text file 0001193125-19-133880.txt   864093
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 19789790
SIC: 2834 Pharmaceutical Preparations